Unknown

Dataset Information

0

Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2- and A?1-42-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.


ABSTRACT: With the lack of available drugs able to prevent the progression of Alzheimer's disease (AD), the discovery of new neuroprotective treatments able to rescue neurons from cell injury is presently a matter of extreme importance and urgency. Here, we were inspired by the widely reported potential of natural flavonoids to build a library of novel flavones, chromen-4-ones and their C-glucosyl derivatives, and to explore their ability as neuroprotective agents with suitable pharmacokinetic profiles. All compounds were firstly evaluated in a parallel artificial membrane permeability assay (PAMPA) to assess their effective permeability across biological membranes, namely the blood-brain barrier (BBB). With this test, we aimed not only at assessing if our candidates would be well-distributed, but also at rationalizing the influence of the sugar moiety on the physicochemical properties. To complement our analysis, logD7.4 was determined. From all screened compounds, the p-morpholinyl flavones stood out for their ability to fully rescue SH-SY5Y human neuroblastoma cells against both H2O2- and A?1-42-induced cell death. Cholinesterase inhibition was also evaluated, and modest inhibitory activities were found. This work highlights the potential of C-glucosylflavones as neuroprotective agents, and presents the p-morpholinyl C-glucosylflavone 37, which did not show any cytotoxicity towards HepG2 and Caco-2 cells at 100 ?M, as a new lead structure for further development against AD.

SUBMITTER: de Matos AM 

PROVIDER: S-EPMC6630837 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H<sub>2</sub>O<sub>2</sub>- and Aβ<sub>1-42</sub>-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

de Matos Ana M AM   Martins Alice A   Man Teresa T   Evans David D   Walter Magnus M   Oliveira Maria Conceição MC   López Óscar Ó   Fernandez-Bolaños José G JG   Dätwyler Philipp P   Ernst Beat B   Macedo M Paula MP   Contino Marialessandra M   Colabufo Nicola A NA   Rauter Amélia P AP  

Pharmaceuticals (Basel, Switzerland) 20190621 2


With the lack of available drugs able to prevent the progression of Alzheimer's disease (AD), the discovery of new neuroprotective treatments able to rescue neurons from cell injury is presently a matter of extreme importance and urgency. Here, we were inspired by the widely reported potential of natural flavonoids to build a library of novel flavones, chromen-4-ones and their <i>C</i>-glucosyl derivatives, and to explore their ability as neuroprotective agents with suitable pharmacokinetic prof  ...[more]

Similar Datasets

| S-EPMC8002093 | biostudies-literature
| S-EPMC7023136 | biostudies-literature
| S-EPMC8746654 | biostudies-literature
| S-EPMC5515920 | biostudies-literature
| S-EPMC7652979 | biostudies-literature
| S-EPMC9124689 | biostudies-literature
| S-EPMC10363122 | biostudies-literature
| S-EPMC5216654 | biostudies-literature
| S-EPMC10965797 | biostudies-literature